Run continuous KOL advisory inside one subscription
Voice and video interviews replace scheduled advisory board meetings. KOLs participate on their own time; you get strategic input without travel coordination or scheduling overhead. Sunshine Act-compatible with full Open Payments data export. Continuous KOL access within the monthly subscription rather than episodic 3-session boards.
KOLs surface label-relevant differentiation insights more consistently in async voice-interview format than in scheduled face-to-face boards.
Trusted by teams at
Traditional pharma advisory boards require flying KOLs to a hotel, honoraria coordination, and weeks of synthesis post-meeting. Carevoices' advisory research runs within the monthly subscription — 50 interviews/month included means continuous KOL/specialist conversations rather than episodic 3-session boards. AI-moderated voice and video interviews let KOLs participate on their own time; fielding starts the same week the brief is locked. Sunshine Act-compatible with full Open Payments data export captured at panelist intake. BAA on every engagement, HIPAA Safe Harbor de-identification, US data residency. Used for medical affairs strategic input, label decision research, brand strategy advisory, and competitive positioning work — and brand teams can run KOL deep-dives, advisory work, and buying-process research all within one subscription cycle.
Why Traditional Advisory Boards Don't Fit 2026 Workflow
Three structural mismatches with modern pharma medical affairs operations.
Sunshine Act / Open Payments documentation overhead repeats every advisory
Every reportable transfer of value to a KOL (honoraria, travel, meals) requires CMS reporting. Coordinating Sunshine Act documentation across 8-12 KOLs, with attribution and breakdown by purpose, plus BAA execution and HIPAA Safe Harbor de-identification, adds 1-2 weeks of administrative work per advisory at legacy vendors and is unbuilt at generic AI tools.
Episodic 3-session advisory boards miss continuous KOL access
Honoraria coordination, travel, hotel, and facility logistics for an 8-12 KOL face-to-face advisory board lock teams into infrequent, episodic engagements (typically 3 sessions per year). Pharma medical affairs teams running quarterly or always-on cadence find the legacy structure unsustainable — they need ongoing voice/video conversations within a continuous engagement rather than 3 isolated meetings.
Scheduling overhead consumes 60-80% of project time
Coordinating 8-12 KOLs across geographies, specialties, and personal calendars takes weeks. Travel, hotel, meal coordination adds 2-3 more weeks. Total elapsed time from project kickoff to face-to-face meeting: 6-10 weeks. Async voice/video reclaims most of that time — fielding starts the same week the brief is locked.
Real-world applications
for Advisory Research
Compliance Built In
BAA on every engagement. HIPAA Safe Harbor de-identification by default. US data residency confirmed in writing. Sunshine Act / Open Payments handling for KOL honoraria — NPI capture, state license, specialty, address captured at panelist intake; CMS-format export with transfer-of-value attribution.
Continuous KOL Access
Monthly subscription enables ongoing voice/video conversations with KOLs rather than episodic 3-session face-to-face advisory boards. AI-moderated voice and video interviews — KOLs participate on their own time, fielding starts the same week the brief is locked.
Always-On Listening
50 interviews/month included means brand teams can run KOL deep-dives, advisory work, and buying-process research all within one subscription cycle — no per-engagement procurement between studies. Strategic input, label work, and competitive positioning under one structure.
How Carevoices advisory research compares to common alternatives
| Dimension | Carevoices | Sermo / M3 panel rentals | ZoomRx / typical RFP-driven CRO | Generic AI tools (Outset / Listen Labs) |
|---|---|---|---|---|
| Engagement model | Monthly subscription with 50 interviews included; continuous KOL access | Annual panel access subscription + per-survey fees | RFP-driven custom advisory engagement, 30-90 day procurement | Custom RFP-driven engagement design |
| BAA on every engagement | Yes — template available pre-signature | Yes — standard for pharma engagements | Yes — standard for pharma engagements | No published BAA template; 60-120+ day legal retrofit |
| AI-moderated voice/video qualitative | Native — primary delivery mechanism for KOL strategic input | Survey + community methodology | Hybrid AI + human moderation, often face-to-face | Yes — but no healthcare compliance package |
| Sunshine Act / Open Payments handling for KOL honoraria | Native — NPI capture + CMS-format export at panelist intake | Available, often as separate workstream | Available, layered onto custom engagement per advisory | Not built — manual retrofit per engagement |
| Continuous KOL access vs. episodic boards | Continuous KOL conversations within one subscription cycle | Per-survey fees; no native continuous capability | Episodic 3-session advisory structure | Custom-scoped per round; no compliance reuse |
From question to intelligence
Brief and panel composition lock
You define the advisory question, panelist mix (specialty, practice setting, geography), and stimuli scope. We recruit and confirm participants within the same week.
AI-moderated advisory interviews
Voice or video interviews with verified clinicians, AI-moderated with structured laddering depth. Stimuli pre-approval workflow runs in parallel for FDA-relevant content.
Compliant deliverable
HIPAA Safe Harbor de-identified transcripts, recordings (if contracted), audit log, and CMS-format Sunshine Act export delivered to your analysis stack.
"We were CROs competing on speed alone, but patient research was the bottleneck — we would quote 8-week timelines while sponsors went to bigger firms in the US and Europe. Carevoices changed the math. We ran 1,203 patient interviews in 48 hours for one sponsor, with HIPAA-grade de-identified transcripts delivered straight into our analysis stack, and the AI moderator went deeper than our human moderators on the first round. Sponsors come to us specifically now because we can do depth research at scale — 34% recruitment uplift, 52% retention. We can now compete globally because of Carevoices."
Stephane Nyombaire, CEO, Nivella Health
How Carevoices Runs Advisory Research
KOL and clinician advisory work needs verified depth, balanced participant rosters, and stimuli pre-approval — all built into the Carevoices subscription.
How we recruit
- License + NPI verification at intake — every advisor's credentials confirmed before the engagement starts
- Specialty + practice setting + employer attestation captured for balanced advisory composition
- Direct NPI outreach for ultra-rare specialties or named-KOL advisory boards
- Sunshine Act / Open Payments handling — NPI capture and CMS-format export for unblinded engagements
How we deliver
- AI-moderated voice or video interviews with structured laddering depth comparable to legacy human moderation
- Stimuli pre-approval workflow with versioning and audit trail for FDA-relevant content
- HIPAA Safe Harbor de-identification on every transcript before sponsor delivery
- BAA executed pre-engagement; US data residency confirmed in writing
Run your next KOL advisory inside one subscription
30-min walkthrough of async advisory research workflow. Sample compliant deliverable. Sunshine Act handling walkthrough.
Sample async advisory deliverable + Sunshine Act handling walkthrough
NPI capture, CMS-format export, transfer-of-value documentation
Most engagements clear procurement within 30-60 days at top-20 pharma.
Common questions
Go deeper on Advisory Research
Pillar Guides
Deep-dive guides covering this topic from strategy to execution.
Tools & Tactics
Practical frameworks and platform-specific guides for teams ready to act.
Alternatives & Comparisons
Side-by-side comparisons with competing platforms and approaches.